Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Youre paying for: Non-medical setups may charge lessbut come with higher risks
The 2019 independent replication paper from a UK-based group examined BPC-157 musculoskeletal soft-tissue findings across an independent set of experimental conditions (PMID 30915550)
Bulk Drug Substances Nominated for Use in Compounding Under Section 503A Category 2 removal of BPC-157, April 22, 2026
Always consult with a healthcare provider before starting any new supplement regimen.
At the molecular level, The compound has been shown to reduce production of tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and other pro-inflammatory cytokines
US$ 29.13
US$ 28.01
US$ 26.81
US$ 26.97
US$ 28.82
US$ 22.02
US$ 20.33
US$ 24.88
US$ 28.37
US$ 28.79
US$ 28.20
